Chemotherapy for testicular cancer induces acute alterations in diastolic heart function

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 891-896

  Van Schinkel, L D ^a   Willemse, P M ^a   Van Der Meer, R W ^b   Burggraaf, J ^c   Van Elderen, S G C ^b   Smit, J W A ^a   De Roos, A ^b   Osanto, S ^a   Lamb, H J ^b  

^a Department of Endocrinology ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PACLITAXEL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; CANCER COMBINATION CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DIASTOLIC DYSFUNCTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FUNCTION TEST; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART STROKE VOLUME; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TESTIS CANCER; TISSUE LEVEL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARDIAC-GATED IMAGING TECHNIQUES; CISPLATIN; DIASTOLE; ETOPOSIDE; HEART; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; SEMINOMA; TESTICULAR NEOPLASMS; TRIGLYCERIDES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 84883151968     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.445     Document Type: Article

References (38)

1. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-A new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5): 469-480.
2. Altena R, de Haas EC, Nuver J, Brouwer CA, van den Berg MP, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2009) Evaluation of sub-Acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer. Br J Cancer 100(12): 1861-1866.
3. Altena R, Hummel YM, Nuver J, Smit AJ, Lefrandt JD, de Boer RA, Voors AA, van den Berg MP, de Vries EG, Boezen HM, Gietema JA (2011) Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer. Ann Oncol 22(10): 2286-2293.
4. Bajraktari G, Koltai MS, Ademaj F, Rexhepaj N, Qirko S, Ndrepepa G, Elezi S (2006) Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Int J Cardiol 110(2): 206-211.
5. Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA (2010) Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov Today Dis Mech 7(2): e135-e143.
6. Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83(1): 59-115.
7. de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11(2): 193-203.
8. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444(7121): 881-887.
9. Devaraj S, Kumaresan PR, Jialal I (2011) C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin Chem 57(12): 1757-1761.
10. Dinh W, Lankisch M, Nickl W, Scheyer D, Scheffold T, Kramer F, Krahn T, Klein RM, Barroso MC, Futh R (2010) Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol 9: 63.
11. Einhorn EH (1997) Testicular cancer: an oncological success story. Clin Cancer Res 3(12 Pt 2): 2630-2632.
12. Haas de EC, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker SJL, van Roon AM, Postma A, Wolffenbuttel BHR, Hoekstra HJ, van Leeuwen FE, Sleijfer DT, Gietema JA (2013) Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol 24(3): 749-755.
13. Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, Meinders EA, Romijn JA, de Roos A, Smit JW (2008) Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 52(12): 1006-1012.
14. Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fossa SD (2010) Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol 28(30): 4649-4657.
15. Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21(8): 1513-1523.
16. International Germ Cell Cancer Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15(2): 594-603.
17. Jonker JT, Lamb HJ, van der Meer RW, Rijzewijk LJ, Menting LJ, Diamant M, Bax JJ, de Roos A, Romijn JA, Smit JW (2010) Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(1): 456-460.
18. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P (2006) Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91(11): 4689-4695.
19. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7): 2402-2410.
20. Lamb HJ, Doornbos J, van der Velde EA, Kruit MC, Reiber JH, de Roos A (1996) Echo planar MRI of the heart on a standard system: validation of measurements of left ventricular function and mass. J Comput Assist Tomogr 20(6): 942-949.
21. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Despres JP (2008) Visceral obesity and the heart. Int J Biochem Cell Biol 40(5): 821-836.
22. Meinardi MT, Gietema JA, van der Graaf WT, van Veldhuisen DJ, Runne MA, Sluiter WJ, de Vries EG, Willemse PB, Mulder NH, van den Berg MP, Koops HS, Sleijfer DT (2000) Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18(8): 1725-1732.
23. Monsuez JJ (2012) Detection and prevention of cardiac complications of cancer chemotherapy. Arch Cardiovasc Dis 105(11): 593-604.
24. Montiel M, Urso L, de la Blanca EP, Marsigliante S, Jimenez E (2009) Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity. Cell Physiol Biochem 23(4-6): 441-448.
25. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31(4): 269-286.
26. Nuver J, de Haas EC, Van Zweeden M, Gietema JA, Meijer C (2010) Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. Oncol Rep 23(1): 247-253.
27. Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van Roon AM, van der Meer J, van den Berg MP, Burgerhof JG, Hoekstra HJ, Sluiter WJ, Gietema JA (2004) Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer 40(5): 701-706.
28. Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van Roon AM, van der Meer J, van den Berg MP, Hoekstra HJ, Sluiter WJ, Gietema JA (2005a) Left ventricular and cardiac autonomic function in survivors of testicular cancer. Eur J Clin Invest 35(2): 99-103.
29. Nuver J, Smit AJ, van der Meer J, van den Berg MP, van der Graaf WT, Meinardi MT, Sleijfer DT, Hoekstra HJ, van Gessel AI, van Roon AM, Gietema JA (2005b) Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23(36): 9130-9137.
30. Paelinck BP, de Roos A, Bax JJ, Bosmans JM, van der Geest RJ, Dhondt D, Parizel PM, Vrints CJ, Lamb HJ (2005) Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45(7): 1109-1116.
31. Pattynama PM, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A (1993) Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology 187(1): 261-268.
32. Raghavan D, Cox K, Childs A, Grygiel J, Sullivan D (1992) Hypercholesterolemia after chemotherapy for testis cancer. J Clin Oncol 10(9): 1386-1389.
33. Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M (2009) Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 54(16): 1524-1532.
34. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ (2008) Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52(22): 1793-1799.
35. Stefenelli T, Kuzmits R, Ulrich W, Glogar D (1988) Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer. Eur Heart J 9(5): 552-556.
36. van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ (2007) Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245(1): 251-257.
37. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108(6): 736-740.
38. Voulgari C, Papadogiannis D, Tentolouris N (2010) Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag 6: 883-903.